Megan Ferguson
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $65,006 of the $82,020 with a category attached, or 79.3%. UCB, Inc. accounts for 89.6% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $39,109, more than ten times the $2,115 reported in 2021. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 465 payments — averaging $176.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$73K
- AbbVie$1K
- Johnson & Johnson$1K
- Sanofi$924
- Sun Pharmaceutical Industries Inc.$730
- Lilly USA, LLC$528
- plus $4K from 19 others
What the payments were for
- Consulting fees$1,4002%
- Speaking & faculty fees$65,00679%
- Travel & lodging$4,6336%
- Food & beverage$10,16612%
- Education$8161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 131 | $73,477 |
| AbbVie | 62 | $1,430 |
| Johnson & Johnson | 45 | $1,183 |
| Sanofi | 31 | $924 |
| Sun Pharmaceutical Industries Inc. | 27 | $730 |
| Lilly USA, LLC | 22 | $528 |
| Incyte Corporation | 13 | $527 |
| Novartis | 21 | $432 |
| Regeneron Healthcare Solutions, Inc. | 9 | $404 |
| Pfizer | 18 | $361 |
| E.r. Squibb & Sons, L.L.C. | 8 | $288 |
| Arcutis Biotherapeutics, Inc. | 10 | $286 |
| Galderma Laboratories, L.p. | 9 | $272 |
| Dermavant Sciences, Inc. | 19 | $254 |
| Amgen | 11 | $237 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $208 |
| LEO Pharma Inc. | 3 | $169 |
| Sanofi-aventis U.S. LLC | 4 | $136 |
| Verrica Pharmaceuticals Inc. | 3 | $51 |
| VYNE Pharmaceuticals Inc. | 2 | $37 |
| Boehringer Ingelheim | 1 | $24 |
| Botanix SB Inc | 1 | $19 |
| Organon | 1 | $15 |
| Biofrontera Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$82,020 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 51 | $3,229 |
| Tacrolimus | 23 | $2,032 |
| Fluorouracil | 18 | $1,730 |
| Ketoconazole | 72 | $1,371 |
| Doxycycline Hyclate | 40 | $1,243 |
| Metronidazole | 21 | $1,176 |
| Fluocinonide | 24 | $1,010 |
| Triamcinolone Acetonide | 93 | $749 |
| Doxycycline Monohydrate | 21 | $453 |
| ValacyclovirValacyclovir Hcl | 19 | $390 |
| Clindamycin Phosphate | 11 | $361 |
| Hydrocortisone | 63 | $245 |
| CiclopiroxCiclopirox Olamine | 13 | $155 |
| Mupirocin | 19 | $150 |
Paid to pharmacies, not to this prescriber.
Other family in Pella
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
- Jaclyn MeisSioux City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.